Get in touch

Submit

Thank you

What is a cloned UK trade mark?

 

To ensure that UK trade mark protection was not lost following Brexit, EU trade mark registrations were cloned onto the UK trade mark register on 1 January 2021. These marks are sometimes referred to as “comparable UK trade marks”, or “UK clones”.  

Why is 31 December 2025 an important date?

 

It is a critical date for trade mark holders because afterwards only use of a mark in the UK will be relevant to support a challenged registration. What this means in practice is that cloned UK marks that are not used in the UK will become vulnerable to revocation for non-use.  

 

What are the key takeaways for the holders of comparable/cloned UK marks?

 

  • Moving forwards, only UK use will support UK trade mark registrations.
  • Check your trade mark portfolio to identify any comparable marks that are only used in the EU; consider whether it is possible to extend use to the UK.
  • It is always good practice to keep detailed use records, but it now even more important to document UK specific use of your trade mark(s) in case you are required to provide it.
  • Don’t leave it to the last minute as this could have catastrophic consequences for your business.

 

If you have any questions, or concerns, please reach out to your usual Keltie contact who will be happy to discuss this further with you.

 

Continue reading about Cloned UK Trade Mark Rights - Deadline Close
MoreTen differences between UK and EU registered designs

05.07.2021

Ten differences between UK and EU registered designs

Since Brexit, EU registered design protection no longer covers the UK. As a result, many design owners and IP practitioners have found themselves filing UK designs for the first time. Are you up to speed on UK practice? Here's a quick-glance guide to the key differences between the EU and UK design systems...

MoreWorking with start-ups – interview with Dev Crease.

24.08.2020

Working with start-ups – interview with Dev Crease.

Dev Crease joined Keltie in 2004 just after he qualified as a UK and European patent attorney. Over past 16 years he has developed a thriving practice in the life sciences, chemical and medical technologies team based around advising rapid growth companies achieve value in their IP positions.

Get in touch

Submit

Thank you